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To address the statistical challenges associated with genome-wide association studies,
we present an independent component analysis (ICA) with reference approach to target
a specific genetic variation and associated brain networks. First, a small set of single
nucleotide polymorphisms (SNPs) are empirically chosen to reflect a feature of interest
and these SNPs are used as a reference when applying ICA to a full genomic SNP array.
After extracting the genetic component maximally representing the characteristics of the
reference, we test its association with brain networks in functional magnetic resonance
imaging (fMRI) data. The method was evaluated on both real and simulated datasets.
Simulation demonstrates that ICAwith reference can extract a specific genetic factor, even
when the variance accounted for by such a factor is so small that a regular ICA fails. Our
real data application from 48 schizophrenia patients (SZs) and 40 healthy controls (HCs)
include 300K SNPs and fMRI images in an auditory oddball task. Using SNPs with allelic
frequency difference in two groups as a reference, we extracted a genetic component
that maximally differentiates patients from controls (p 4 × 10−17< ), and discovered a
brain functional network that was significantly associated with this genetic component
(p < 1 × 10−4). The regions in the functional network mainly locate in the thalamus,
anterior and posterior cingulate gyri. The contributing SNPs in the genetic factor mainly fall
into two clusters centered at chromosome 7q21 and chromosome 5q35. The findings from
the schizophrenia application are in concordance with previous knowledge about brain
regions and gene function. All together, the results suggest that the ICA with reference
can be particularly useful to explore the whole genome to find a specific factor of interest
and further study its effect on brain.
Keywords: independent component analysis with reference, genome-wide association study, brain network,
schizophrenia, single nucleotide polymorphisms, functional magnetic resonance imaging
INTRODUCTION
Considerable research suggests that complex genetic factors con-
tribute to the etiology of mental diseases including Alzheimer’s,
Parkinson’s and schizophrenia (Serretti et al., 2007; Allen et al.,
2008; Simon-Sanchez et al., 2009). For instance, schizophrenia is
highly heritable, with heritability of 0.6–0.8 (Rao et al., 1981) and
the concordance between identical twins is about 50% (Cannon
et al., 1998), suggesting roles for both genetic and environmen-
tal influences. Linkage studies on family samples and association
studies on population samples both identify multiple genetic vari-
ants associated with the disease (Hovatta et al., 1998; Levinson
et al., 2000; Fan et al., 2006; Purcell et al., 2009). One way to test
the genetic risk is to perform a focused study on a selection of spe-
cific genes or chromosome loci, which are hypothesized to relate
to the disorder-based on a priori knowledge of the molecular
and cellular functions. While useful, this approach may overlook
genetic elements that have not yet been studied but may actu-
ally play an important role in a given disorder. This limitation,
combined with the known genetic complexity of many diseases,
provides strong motivation for performing a broad genome-wide
association study (GWAS) on a large number of single nucleotide
polymorphisms (SNPs).
GWAS methods enable the study of genes that have not been
studied or that have been understudied for a particular disease
(Hirschhorn and Daly, 2005) and thus, hold considerable poten-
tial for identifying genes associated with complex genetic illnesses
(Hindorff et al., 2009). Unfortunately, GWAS is not without its
own shortcomings. The main challenge is a statistical power lim-
itation, which is further exacerbated if only a limited number of
subjects are available. To balance a small sample size and a large
volume of SNP data, a set-based approach has been proposed that,
instead of testing the association of each genetic marker one by
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one, tests the overall effect of multiple markers grouped by genes
(Liu et al., 2010) in hope of a larger effect size and increased sta-
tistical power. Similar is a factor-based GWAS approach, where a
factor comprises multiple markers carrying a related pattern.
Among many factorization methods, independent component
analysis (ICA), multiple regression, and partial least squares have
been applied in GWAS. For example, ICA or parallel ICA (Liu
et al., 2008) has been implemented to identify genetic factors and
associated phenotypic factors (Lee and Batzoglou, 2003; Dawy
et al., 2005; Liu et al., 2009). A genetic factor is a weighted com-
bination of multiple loci statistically associated, while different
alleles contribute with different effect size to a phenotype. The
number of independent factors extracted and analyzed is remark-
ably smaller than the number of genetic markers, which serves
as a high-dimension reduction function. Recently, Vounou and
colleagues proposed a sparse reduced-rank multiple regression
to discover genetic associations with neuroimaging phenotypes,
wherein the reduced-rank regression was employed to tackle the
dimension reduction and a sparsity control was used to select
highly predictive genetic markers (Vounou et al., 2010). These
methods all have shown an ability to extract factors accounting
for major variance from genetic data. Yet, in some cases, par-
ticularly with up to a million loci, researchers are still facing
challenges in extracting factors of specific interest that may not
carry a large amount of variance in the genome. In this paper we
present a procedure to extract a maximally independent genetic
factor of a particular interest by using ICA with reference, where
ICA is constrained with a user-defined reference. We then are
able to investigate the relationship of this particular genetic factor
with brain function by using functional networks extracted from
functional magnetic resonance imaging (fMRI) as phenotypes.
Using brain function measured by fMRI data has become
popular recently as an intermediate phenotype for genetic stud-
ies of mental illnesses. For complex genetic mental disorders
such as schizophrenia, structural and functional alterations in
the brain have been observed consistently including major
deficits in dorsolateral prefrontal cortex (Weinberger et al., 1986;
Potkin et al., 2009), superior temporal lobe (Calhoun et al.,
2008; Sun et al., 2009), etc. Meanwhile, multiple alleles, genes,
and their interactions (Prata et al., 2009; Meda et al., 2010)
have shown to modulate the risk to schizophrenia (current
reports are available at the schizophrenia forum gene list at
http://www.schizophreniaforum.org/). All the brain abnormali-
ties together with the genetic complexities make schizophrenia a
good target of our proposed reference ICA approach with brain
functional phenotypes.
In this study, we test our method on both simulated and real
datasets for association between fMRI and SNPs. The real data
were obtained through the Functional Biomedical Informatics
Research Network (FBIRN), a multi-site study sponsored by the
NCCR/NIH which included the development of multi-center
fMRI techniques with schizophrenia-related fMRI data collection,
and genetic sample collection (Friedman et al., 2008; Potkin and
Ford, 2009). The fMRI data were collected from subjects as they
performed four sessions of a two-tone auditory oddball task. This
task was selected given that previous studies have consistently
linked schizophrenia with deficits in both strength and extent
of activation during auditory target detection tasks (Kiehl and
Liddle, 2001; Li et al., 2002).
METHODS AND SIMULATION
OVERVIEW OF DATA ANALYSIS APPROACH
We propose a multistep approach to identify a specific (e.g.,
disease-related) genetic variation and the associated brain net-
works using a guided version of ICA. A flowchart of our approach
is shown in Figure 1. The starting point is to find reference
markers that present prominent feature of interest. The refer-
ence markers can be derived from prior knowledge about genes’
function or data pattern. Once identified, these markers (called
a reference) are used to guide the ICA process to extract an
independent componentmaximally representing reference’s char-
acteristics from a much large array. This process is known as ICA
with reference. While extracting the independent component,
ICA also outputs a set of subject-specific loading coefficients,
which describe the presence of the identified component across
subjects. We then extract brain functional networks from fMRI
images using a regular ICA, where each fMRI component iden-
tified presents a brain network. Finally, we correlate the loading
coefficients of the resulting fMRI components to the loading
coefficients of the SNP component to identify linked SNP/fMRI
component pairs and their relationship.
REFERENCE GENERATION
As mentioned above, a reference can be generated in many ways,
such as from a particular feature in the genetic data, or from
a hypothesized pathway or a cluster of prior loci. For the pur-
poses of this study we assume that the true susceptible loci show
prominent differences in allelic frequency between patients and
controls, and a majority of them are operating together. Based on
this assumption, we identify the SNPs showing group differences
using a two-sample t-test p < 0.0001 (uncorrected for multiple
tests, empirically chosen for conveying the pattern of interest,
and, at the same time, not introducing irrelevant data) as the ref-
erence. This reference selection is not meant to claim these SNPs
are significant at a GWAS level, but to identify a pattern of interest.
FIGURE 1 | The flowchart of the proposed method.
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The location of the reference SNPs provides a set of weights to
guide the ICAwith reference to find the best SNP factor associated
with the disease in the sample.
ICA WITH REFERENCE ON SNPs
ICA is a generic technique that extracts a set of underlying com-
ponents or factors from a set of random variables or observations.
The components themselves are assumed to be mutually inde-
pendent and linearly mixed into observations. Explicitly, if we
consider n component signals s = [s1, s2, . . . sn]T and assume
they are linearly mixed together to produce m observations, the
generative model can be written as x = As, where A is the mixing
matrix. Elements of A are often referred to as mixing or loading
coefficients. ICA attempts either to estimate the mixing matrix A,
or find its pseudo-inverseW referred to as the de-mixing matrix;
so that the elements of y = Wx are a good representation of s,
the component signals. The estimation and optimization ofW is
based upon the assumption of mutual independence between the
component signals.
ICA with reference is based on one ICA algorithm, the FastICA
algorithm (Hyvirinen and Oja, 1999; Bingham and Hyvarinen,
2000), where the negative entropy is used to measure mutual
independence in a formula asmax: J(y) ∼ [E{G(y)} − E{G(ϕ)}]2.
ϕ is a standardized Gaussian variable and G(·) is a non-quadratic
contrast function. While optimizing J(y), the Kuhn–Tucker con-
ditions can be used along with the notation y = wTx and the con-
straint ||w||2 = 1 to yield an update on the rows of W, such that
wk = E[xG′(wTk−1x)] − E[G
′′
(wTk−1x)]wk−1. If a function G′(u) =
u3 is chosen, the update becomes wk = E[x(wTk−1x)
2] − 3wk−1.
Inspired by this form of the update, it is possible to impose
an additional constraint which incorporates prior information
about the components (Barros and Cichocki, 1998; Lin et al.,
2007). Such a method has previously been applied to fMRI data
(Lin et al., 2010) and is implemented within the GIFT toolbox
(http://icatb.sourceforge.net). If the components are also known
to be sparse, i.e., only have activity of interest in a small section of
all variables, which is true for most genetic factors in the genome,
then that information can also be incorporated into the previous
update on w by considering wk = E[x|wTk−1x − r|
p
sign(wTk x −
r)] − 3wk−1, where r is a reference signal containing source activ-
ity information, and |·|p is a p-norm based closeness measure.
This update is no longer maximizing just the independence, but
finding the maximally independent source which is close in the
|·|p sense to the reference. Strictly speaking the update no longer
produces maximally independent sources; however, it is often
reasonable to relax the independence assumption when there
is sufficient prior information about the component structure
(Barros and Cichocki, 2001).
Using the reference identified in Section “Reference
Generation,” we apply the ICA with reference to the large
SNP data to determine the component with the closest distance
to the reference. In detail, the input to the ICA with reference
includes anM-by-P SNP matrix, whereM is the number of sam-
ples and P is the number of SNP loci in a range of 10,000–300,000
in this study. The SNP data are coded as 0, 1, or 2, indicating the
load of minor alleles. A reference is also provided that is a 1-by-P
vector consisting of 0 s and 1 s with 1 denoting reference loci. The
identified SNP component by the ICA with reference represents
a maximally independent genetic factor comprising multiple
SNPs, of which each has its specific contribution, and may
come from different genes or even different chromosomes, but
carries covaried distribution across subjects to be classified into
one genetic factor. Since this factor is derived using a reference
with different allelic frequency between groups, we expect it
to differentiate patients from controls, which can be verified
through a two-sample t-test. Here the purpose of the t-test is
not for significance of group difference (which is biased due to
the reference), but for verification of the property of the desired
component. For interpretation of our results, we normalize the
contribution weights of the component (using z-transform) and
select only the top 0.05% SNPs in the contribution distribution
(including positive and negative). This conservative cut-off
(similar to α = 0.0005) provides us with a subset of SNPs which
contribute the most to the component. To further analyzing the
inter-relation among the top SNPs, we perform cross-correlation
tests on the genotypes of these SNPs across subjects and linkage
disequilibrium (LD) test. The D′ (normalized LD) values between
pairs of SNPs were calculated by the PLINK tool (http://pngu.
mgh.harvard.edu/∼purcell/plink/).
ICA ON fMRI
Since brain function is the phenotype of this study, we extracted
independent brain networks from fMRI images using a regular
(blind) ICA, the infomax algorithm (Bell and Sejnowski, 1995).
Infomax requires estimating the number of independent com-
ponents first. To determine this number, we performed both
the modified minimum descriptive length algorithm (Li et al.,
2007) and the Akaike information criteria test (Akaike, 1974) and
used the rounded average of their results. After fMRI component
extraction, we correlated the subject-specific loading coefficients
of the fMRI components with those from the SNP component.
With 0.05 Bonferroni multiple comparison correction, we iden-
tified the significantly correlated SNP-fMRI components, which
suggest that the genetic factor has influence on brain function of
the identified brain network.
PERMUTATION TEST
To validate our findings on the association between the genetic
factor and fMRI networks, we conducted a 10,000-permutation
test, by permuting schizophrenia patient (SZ) or healthy con-
trol labels of the SNP data and repeating steps 2.2–2.4. Thus,
we generated randomly references for the SNP data in each per-
mutation, and extracted a SNP factor and tested its correlation
with the fMRI components accordingly. With the 10,000 permu-
tations, we are able to build a distribution of null hypothesis about
the correction between the genetic factor and brain networks and
examine the significance of the true correction.
SIMULATION TEST ON THE ICA WITH REFERENCE
A simulation was designed to validate the capability of ICA
with reference to extract factors of interest, in particular for
genomic SNP data.We used the simulation tool in PLINK (http://
pngu.mgh.harvard.edu/∼purcell/plink/) to generate a set of 200
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subjects and 10,000 SNPs of genotype data with minor allele fre-
quencies (MAF) ranging from 0.01 to 0.5. Although the ICA with
reference method is designed to extract any factor of interest, such
as a factor of a particular pathway, we simulated a simple case in
terms of easy evaluation, which is to extract factors discriminat-
ing patients from control groups. We selected six sets of SNPs,
each with 10–100 loci, as causal loci for six types of diseases,
respectively (these causal SNP loci are not in LD with max cor-
relation < 0.25), and superimposed correlations into these causal
loci and diagnostic phenotypes (six sets of diagnoses, each with
half patients and half healthy controls). The superimposed corre-
lation between individual causal locus and diagnosis ranged from
0.20 to 0.50, resulting in effect sizes of 0.04–0.25 (percentage of
variance explained). It can be seen that some causal loci have very
low effect size, even lower than averaged random loci of 0.08. The
reference is the location of a handful of SNPs that comprise dif-
ferent proportions of simulated true causal loci and false causal
loci. We compared the performance of the reference ICAwith that
from a regular Infomax ICA. We tested whether the right factor
is extracted and the factor’s effect size under different configu-
rations of the reference accuracy (the fraction of true causal loci
in the reference), and reference length (the number of reference
loci relative to the number of all causal loci in the simulation
data). Because the targeted factors are the ones discriminating
patients from controls, we can further evaluate the sensitivity,
specificity, and area under ROC curve (AUC), after thresholding
the contribution weight of factors to pick the top contributing
loci. To increase the validity of all tests, results presented here were
obtained after averaging the six diseases conditions.
APPLICATION IN SCHIZOPHRENIA
SUBJECTS
Subjects used in the real data application were part of
FBIRN Phase II study (Kim et al., 2009; Potkin et al., 2009),
recruited from seven universities (Duke/University of North
Carolina, University of Iowa, Massachusetts General Hospital,
University of California–Irvine, University of California–Los
Angeles, University of Minnesota and University of NewMexico).
All participants provide written informed consent approved
by local institutional review board. SZ group met criteria for
schizophrenia or schizoaffective disorder-based on the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition.
Healthy controls (HC) were free of a personal or family (first-
degree relatives) history of major axis I psychiatric illness. See the
detail in (Kim et al., 2009; Potkin et al., 2009). Out of 186 avail-
able subjects, 90 subjects had both genetic and fMRI data from an
auditory oddball task. Two subjects were further removed because
of problematic fMRI data (motion rotation > 1.4◦, translation
> 4.5mm). Thus, 40HC subjects and 48 SZ patients were ana-
lyzed in the following application. The patients and controls were
similar in handedness, age, race, and parental education level,
but the patients had significantly lower IQs and fewer years of
education than the HC subjects. See Table 1 for a comprehensive
presentation of subject demographic data.
fMRI TASK AND CONFIGURATION
fMRI images were collected during an auditory oddball task,
which consisted of a series of frequent standard (1000Hz, 95%)
or target (1200Hz, 5%) 100ms duration tones presented every
500ms. Subjects were instructed to press a button with their right
hand as quickly as possible whenever a target tone was presented.
See Kim et al. (2009) for more detailed information about the
design of the experiment and the data collection procedures.
Based on performance during preliminary studies, the FBIRN
consortium matched their pulse sequence parameters to the
greatest extent possible across all sites. The parameters were as
follows: slice thickness = 4mm, field of view = 22 cm, flip
angle = 90◦, voxel dimensions = 3.43 × 3.43 × 4mm, number
of slices = 27, matrix = 64 × 64, repetition time = 2 s, and echo
time = 30ms (3T)/40ms (1.5T). The fMRI data were analyzed
using statistical parametric mapping software version 5 (SPM5)
(http://www.fil.ion.ucl.ac.uk/spm/software/spm5/). fMRI images
were motion corrected using INRIalign image realignment, slice-
timing corrected, spatially normalized to Montreal Neurological
Imaging (MNI) space and then spatially smoothed using a 9 ×
9 × 9mm full width at half maximum Gaussian kernel. The gen-
eral linear model was applied to get the response maps for the
target tone and standard tone, and the target tone minus stan-
dard tone contrast image was extracted for each subject. An
additional mask was applied to remove voxels from CSF and
Table 1 | Subject demographic information and IQ measurements.
Demographics Schizophrenia [Mean (SD)] Healthy controls [Mean (SD)] t/p Value
Sex (male/female) 29/19 20/20 −
Race (Caucasian/African American/Asian/Mixed) 38/8/2/0 34/2/2/2 −
Handedness (R/L) 44/4 38/2 −
Age (in years) 38.06 (10.98) 35.29 (10.99) 1.185/0.23
Maternal education (in years) 13.26 (2.99) 14.44 (2.41) −1.95/0.054
Paternal education 14.07 (3.47) 14.89 (3.29) −1.08/0.28
Subject education 13.70 (1.912) 15.67 (1.81) −4.8/7.18E-6
Verbal IQ 103.98 (10.21) 110.79 (6.88) 3.54/7.16E-4
Performance IQ 107.88 (5.07) 110.95 (3.25) 3.27/1.7E-3
Full scale IQ 102.13 (8.96) 112.1 (6.03) 3.54/7.16E-4
Note: IQ data was missing seven subjects from the SZ group.
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regions outside the brain. These contrast images were then used to
identify independent brain networks as intermediate phenotypes.
GENOTYPING AND PREPROCESSING
DNA samples from 186 subjects were genotyped at 308,330
SNP loci in autosomes using Illumina HumanHap300 BeadChip
arrays. The SNP arrays were preprocessed using PLINK V1.07
(http://pngu.mgh.harvard.edu/purcell/plink/). A total of six sub-
jects and 6,509 SNP loci were removed because fewer than 90% of
their markers were genotyped correctly. No subject failed the het-
erozygosity outlier test or the test for second-degree and closer
relatedness. The Hardy–Weinberg Equilibrium test in controls
eliminated 11 SNP loci with a cut-off p < 10−6. Missing geno-
types were replaced with the genotypes of the SNPs in the highest
LD > 0.8, if available. Otherwise the SNP loci (28,809 SNP loci)
were removed. A minor allele frequency of 0.01 was used and
resulted in 272,808 SNP loci. These SNPs were coded as 0, 1,
2, indicating the number of minor alleles based on an additive
model. Though a three dimensional orthogonal coding (Hardoon
et al., 2009) can handle all three models: additive model, domi-
nant, and recessive model, the number of data variables will be
increased by a factor of three. In this study we choose the additive
model as themost general, and do not want to increase the already
large number of data variables. An eigenvalue based approach
(Price et al., 2006) was applied to remove population structure
effect. Two population stratification components were removed
due to significant correlation with race information. Afterward,
a Quantile-Quantile plot shows no clear population stratification
indication with λ = 1.005.
RESULTS
SIMULATION RESULTS
Simulated data are 10,000 SNPs’ genotypes coded as 0, 1, and 2
from 200 subjects. Six types of disease conditions were built in
with each involving 10–100 causal loci and affecting half of sub-
jects. The targeted factors in this simulation are those related to
each disease. Our simulation results show that, in most cases (five
out of six disease conditions in some simulation runs, and six
out of six in others), regular ICA is unable to extract the super-
imposed disease-related genetic factors due to the small variance
accounted for by such factors. Instead, it extracts other factors
embedded in the genomic data with large within-sample vari-
ances. In contrast, the ICA with reference can extract the right
factors under most conditions except when the reference accu-
racy is really low. With a reference with low accuracy, as indicated
by asterisks in Table 2, the ICA with reference functions like the
regular ICA and produces the same outputs as the regular ICA.
When we have the right factors extracted, we calculated the
sensitivity, specificity, and AUC to provide more information
about the accuracy of the factors. The sensitivity and specificity
to identify causal loci are functions of the Z-score threshold that
measures the contribution of each locus to the genetic factor,
compared with the ground truth about causal loci. Since the reg-
ular ICA cannot extract the right factors in general, the sensitivity
and specificity were low and not presented, but similar as the
results from the reference ICA under special configurations. In the
ICA with reference results, we presented in Table 2 the sensitivity
and specificity for the z-score of 2.5 as a typical example, the AUC
and the total factor effect size along with different reference con-
figurations. The results inTable 2 are the averaged results from six
disease conditions. When the reference accuracy is above 0.5, or
the reference accuracy is 0.5 and the reference length is above 0.2,
the right components were extracted with increased sensitivity of
detecting the true causal loci compared with known true causal
loci in the reference. But, as shown in Table 2, when the refer-
ence accuracy is only 0.25 or the reference length is 10–20% with
50% true causal loci, the reference ICA fails to extract the disease-
related factors, functions just like the regular ICA, and extracts
Table 2 | Simulation results using 200 subjects and 10,000 SNPs.
Reference length Reference accuracy AUC Sensitivity (Z = 2.5) Specificity (Z = 2.5) Discovered total factor effect size
0.1 1 0.94 0.30 0.99 0.28
0.2 1 0.97 0.53 0.99 0.47
0.4 1 0.99 0.71 0.99 0.62
0.5 1 0.99 0.73 0.99 0.64
0.1 0.75 0.93 0.24 0.99 0.25
0.2 0.75 0.91 0.37 0.99 0.31
0.4 0.75 0.98 0.63 0.99 0.52
0.5 0.75 0.98 0.63 0.99 0.51
0.1 0.5 0.82* 0.13* 0.99* 0.11*
0.2 0.5 0.85* 0.23* 0.99* 0.17*
0.4 0.5 0.93 0.44 0.99 0.32
0.5 0.5 0.94 0.45 0.99 0.33
0.1 0.25 0.69* 0.06* 0.98* 0.04*
0.2 0.25 0.72* 0.07* 0.98* 0.04*
0.4 0.25 0.80* 0.12* 0.98* 0.09*
0.5 0.25 0.82* 0.16* 0.98* 0.09*
Note: *Indicates that a non-disease-related factor was extracted with an effect size same as a random locus.
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factors with the effect size and sensitivity in the range of random
loci. Results measured by AUC, sensitivity, and factor effect size
are in agreement with each other. We also conducted a simula-
tion with 90 subjects and 230,000 SNPs, a similar scenario to the
real data application. The results are very similar to Table 2 (not
shown). Therefore, we assume that in the real data application at
least 25% of the reference markers are true causal loci (or tagging
loci) for phenotypes of interest.
RESULTS FROM THE APPLICATION IN SCHIZOPHRENIA
In the real application of 88 subjects’ SNP genotypes from
272,808 loci, only 25 SNP loci showed a difference between
the HC and SZ groups at an uncorrected p-value less than
1 × 10−4. The location of these 25 SNPs (rs7570354, rs11711733,
rs152442, rs10953026, rs2279834, rs1039898, rs10511304,
rs2173096, rs511411, rs382321, rs3731920, rs955411, rs4105175,
rs17826681, rs1017528, rs1391927, rs7341022, rs1468708,
rs9314788, rs1124941, rs2172557, rs6596651, rs2286696,
rs1284108, rs1419005) was used as the reference for our ICA
with reference analysis on the entire SNP dataset (88-by-272,808
matrix). The extracted SNP component, as we expected, dif-
ferentiates SZ patients from controls with much lower loadings
in patients (p-value of 4.10 × 10−17. This p value is not meant
for unbiased significance, but for verification of the desired
property of the genetic factor. The significance of this factor’s
association with brain function is the targeted test). This SNP
component was not confounded by gender and handedness,
tested by ANOVA. After normalizing the contribution weights in
the identified SNP component using a z-transform, we selected
the top 26 SNPs that contribute most, which lie in the top 0.05%
of all SNPs contribution distribution in the component (SNPs
with a |Z|-score greater than 4.68; the contribution weight can
be positive or negative). These SNPs, their corresponding genes,
chromosome position, and MAF in patients and controls are
shown in Table 3. All these loci exhibit different MAF between
patients and controls (p value ranging from 2.74 × 10−6 ∼ 0.04),
with some minor alleles more frequent in patients and some in
controls.
To investigate the possible inter-SNP-relationship, we
performed cross-correlation tests on the genotypes of 26
contributing SNPs across subjects. Figure 2 presents all corre-
lations stronger than 0.35 (P < 0.001), which forms two big
clusters. One is centered at chromosome 7q21 region includ-
ing rs10953026, rs2286696, rs758706, rs3824039, rs2188240,
rs1110457, rs7669821, rs2381387, and rs1419005, mainly involv-
ing gene CDK14,NXT1, andUGDH. The other cluster is centered
Table 3 | Top component SNPs by weights and associated genes.
SNP Contribution weights MAF: patient MAF: controls Chromosome position Gene
rs10953026* 7.11 0.22 0.54 7q21.13 CDK141
rs2286696* 6.7 0.29 0.61 7q21.13 CDK141
rs4105175* 6.6 0.29 0.55 5q35.3 ZNF8792
rs2173096* 6.39 0.28 0.55 5q35.3 Between genes GRM6 and ZNF8792
rs758706 −6.12 0.56 0.31 7q21.13 CDK141
rs2067011 −5.79 0.58 0.30 5q35.3 GRM62
rs1889574 −5.65 0.46 0.26 13q12.11 LOC 1005069712
rs7669821 5.53 0.36 0.54 4p14 UGDH1
rs2279834* 5.31 0.10 0.39 12q23.1 SLC5A8
rs1406002 −5.11 0.48 0.33 2p15 Intergenic
rs1468708* 5.10 0.21 0.51 6q24.1 Intergenic
rs1284108* 4.99 0.24 0.51 11q21 Near MED17 (<20 kbp)
rs1017528* 4.89 0.21 0.41 17q22 Near CUEDC (< 30 kbp)
rs1445846 4.88 0.23 0.44 5q35.3 ZNF354C2
rs1445845 4.88 0.23 0.44 5q35.3 ZNF354C2
rs1445844 4.88 0.23 0.44 5q35.3 ZNF354C2
rs11750568 4.88 0.23 0.44 5q35.3 ADAMTS22
rs1419005* 4.88 0.23 0.51 20p11.21 NXT1 (<1 kbp)1
rs887780 4.87 0.24 0.41 6q24.1 Intergenic
rs3824039 −4.86 0.54 0.33 7q21.13 CDK141
rs2188240 −4.85 0.54 0.33 7q21.13 CDK141
rs1110457 −4.85 0.54 0.33 7q21.13 CDK141
rs2839081 4.80 0.36 0.56 21q22.3 Near COL6A1 (<20 kbp)2
rs6991271 −4.80 0.59 0.34 8p12 KIF13B
rs2381387 4.70 0.30 0.51 4p14 Near UGDH1 (<3 kbp)
rs1487074 −4.68 0.40 0.23 2p15 Near EHBP1 (<10 kbp)
Table is sorted by SNP weights. *Indicates the SNP overlapping with the reference SNPs. MAF (minor allele frequency) was calculated based on our dataset. Two
clusters are indicated by superscript 1 and 2.
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FIGURE 2 | Cross-correlation among the top 26 SNP loci. All correlations
stronger than 0.35 were plotted (p < 0.001). Two big clusters were
identified; one is centered at chromosome 7q21, including rs10953026 and
rs2188240. The other is centered at chromosome 5q35 including rs4105175
and rs1445846. See text for the detail list of SNPs.
at chromosome 5q35 region including rs4105175, rs2173096,
rs2067011, rs1445846, rs1445845, rs1445844, and rs11750568,
mainly involving gene GRM6 and ZNF354C. No linear corre-
lation exists between these two clusters. The LD tests among
the identified 26 SNPs using 180 subjects’ data show consistent
pattern with the correlation map. The 6 SNPs at 7q21 region are
in high LD with D′ of 0.76 ∼ 1, and the 7 SNPs at 5q35 region
are also in LD with D′ of 0.74 ∼ 1. The two SNPs at 2p15 are in
LD with D′ as 0.93, so are the two SNPs at 4p14 with D′ as 1.
Infomax ICA was performed on the fMRI contrast images to
extract functional brain networks. Based upon the dimension-
ality estimation, we identified five spatially independent fMRI
components. Of the five fMRI components, a single component
was identified to be significantly correlated with the SNP compo-
nent (shown in Figure 3), with a correlation of 0.39 (p < 0.0001,
passing Bonferroni correction for multiple comparisons). The
loading coefficients of the linked fMRI and SNP components are
plotted in Figure 4, where the positive correlation indicates that
activity in the network shown in Figure 3 increased as the pres-
ence of SNP component increased, with 15% of brain activity
variance explained by the SNP component. The post-hoc ANOVA
tests did not detect any main effect from gender, data collec-
tion site, or handedness for this fMRI component. Yet, this fMRI
component shows a significant difference between the SZ and
HC groups (p < 0.0001) on the loading coefficients, which is
in accordance with the hypothesis that the genetic risk factor
to SZ alters the brain function that also differentiates patients.
Permutation results show that the correlation of 0.39 between
the genetic factor and brain network has a 0.02 false positive rate
among 10,000 random runs.
DISCUSSION
ICA with reference is designed for the extraction of component
corresponding to a particular interest. Our goal in this study
is not to develop a better classification/discrimination method
such as linear discriminant analysis, yet to extract factors of any
FIGURE 3 | The fMRI component linked to the SNP component.
(A) Activation map with |z | value > 6 while responding to target vs.
standard stimuli in the auditory oddball task. Red to yellow color indicates
positive activation regions, while blue indicates deactivation regions.
(B) A list of regions and volumes with |z | value > 6. The activation regions
mainly include thalamus, anterior cingulate and posterior cingulate gyri and
deactivation regions are mainly in left pre- and post-central gyri. Note that
the pre- and post-central gyri are mainly positively activated during the task,
and the deactivation in this component is only fraction of activation that
covaries with positive activation in thalamus, cingulate gyrus, etc.
FIGURE 4 | The loading coefficients of the linked SNP and fMRI
components. The X and Y axis are the loadings for SNP and fMRI
components, respectively. The positive trend shows the positive correlation
(r = 0.39, R2 = 0.15) between these linked components. Healthy controls
demonstrates strong positive presence of the SNP component and higher
activation in the fMRI component, while schizophrenia patients carry
negative presence of the SNP component (opposite combination of minor
alleles in the SNPs), and lower activation in the fMRI component.
interest, in particular when the variance carried by such factors is
small. In the simulation we only compared the ICA with reference
method with a regular ICA method to improve or extend the ICA
application to large genetic data.
The simulation results demonstrate that the reference does
help to extract the factor of interest, even when the variance
accounted for by the factor is very small and regular ICA failed
to identify it. It is necessary to point out that the accuracy of the
reference is far more critical to the success of the method than the
number of loci in the reference. Table 2 shows that AUC is highest
when the reference accuracy is maximized. With the same accu-
racy, the length of the reference also has an impact on sensitivity
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and factor effect size. Not surprisingly, the simulation shows that
when the reference is irrelevant to the disease, i.e., many false loci
are added, reference ICA extracts a factor either totally unrelated
to the disease (In Table 2 * notes sensitivity and factor effect size
close to that from a random individual locus), or with reduced
sensitivity and factor effect size. For instance, using only 10% of
fully accurate loci produced a higher sensitivity/factor effect size
than using 50% of loci of which only half are accurate, equaling to
25% accurate loci. The factor effect sizemeasures the overall effect
from multiple small-effect causal loci, calculated by the loadings
of the factor and expected to be higher than that from each indi-
vidual causal locus. The simulation clearly shows that when the
right component is extracted, the factor’s effect size (> 0.25) is
much higher than individual causal locus (0.04–0.25). We are
aware that the identification of false positive loci implies that there
is certainly room for improvement of the method. Most impor-
tantly, the simulation results indicate that even for an imperfect
reference (allowing for a maximum of 75% of the reference mark-
ers to be incorrect), our method can extract the factor of interest
with increased sensitivity, compared to both regular ICA results
and known true reference.
For our real data application to a schizophrenia study, we used
SNPs that show group differences as the reference for ICA with
reference on the entire genetic data set. Even though we are uncer-
tain that all the reference SNPs are the true SZ susceptibility SNPs
(or their tagging SNPs), we assume that the true susceptibility loci
show prominent differences between patients and controls, and a
majority of them are operating together. In the simulation, we
proved that as long as 25% of reference loci are true loci or in
LD with true loci, then our method can extract the genetic fac-
tor with increased sensitivity. Although in the real application we
do not know whether 25% of reference SNPs are true SZ suscep-
tibility loci or in LD with true loci (given only 88 samples are
used, the fact of 25% of reference SNPs being true SZ suscepti-
ble becomes more questionable), this limitation does not affect
the method ability to extract a genetic factor differentiating SZ
patients from controls in our sample. As a result, 26 SNPs were
identified contributing to a genetic component/factor showing
significant differentiating power on SZ. Among them, 9 loci over-
lapped with those from the reference, reflecting the guidance by
the reference. The dissimilarities between the identified SNPs in
the component and the reference reflect the presence of other
SNPs that co-vary with the identified SNPs, but do not show the
most significant group difference. Two big clusters found in the
26 SNPs imply that the SNPs may be from different chromosome
locations, two major related genetic functions are involved, and
the involved SNPs/genes interact together in contributing to the
factor that differentiates patients from controls. Essentially, our
method serves as a targeted way to extract information embedded
in the genome. This approach has many potential applications
such as the extraction of a certain pathway-related component
from the whole genome.
To study brain functional networks via ICA is a well-
established approach (Calhoun et al., 2001; Calhoun and Adali,
2006). Of the five fMRI components extracted in this applica-
tion, one was significantly correlated with the genetic component,
not confounded by gender, collection sites, and handedness (the
medication may affect the brain function since all patients except
one are under stable doses of psychotropic medication, which
is the limitation of this application). The permutation test con-
firmed this association is within a 0.02 false positive control.
The positive correlation between the SNP and fMRI compo-
nents suggests that the overall effect of this genetic factor is
related to a higher activation in regions of this fMRI component.
Since each SNP in the genetic factor contributes differently to
the factor, some minor alleles such as one in rs10953026 posi-
tively relate to increased activation of the fMRI component, and
some minor alleles such as one in rs2067011 relate to decreased
activation of the brain network. These differences of SNP con-
tribution also reflect their allelic frequency in SZ patients and
controls, i.e., MAF of some SNPs is higher in patients, and of
others is higher in controls. The identified functional component
was mostly notably contained in the cingulate gyrus (anterior
cingulate and posterior cingulate) and the thalamus, where SZ
patients showed a lower level of activity while responding to
target sounds than HCs. The cingulate gyrus, particularly ante-
rior cingulate, is also one of the most studied regions for SZ,
where functional and anatomical alterations have been reported
in numerous strands of investigations, reviewed by Adams and
David (2007) and Fornito et al. (2009), respectively. The thalamus
plays a key role in information relay; a defect in connecting the
thalamus with frontal cortex and cerebellum could easily explain
a wide range of schizophrenia related symptoms. As neuropathol-
ogy and imaging studies suggested, patients with schizophre-
nia may have abnormalities in this circuitry (Andreasen, 1997;
Shenton et al., 2001; Watis et al., 2008). Our result linking the
genetic factor that differentiates SZ patients from controls to
the functional differences in these regions is in accordance with
the previous knowledge and further increases our confidence on
the method.
We were also encouraged by the fact that some of the genes
listed in Table 3 have a direct link to brain function. As pre-
sented in the results, these genes are centered at two big clusters,
around CDK14 (7q21) and GRM6 (5q35). CDK14 encodes the
cdc2-related protein kinase, PFTAIRE, that is expressed in post-
mitotic neuronal cells both in the brain and the embryo (Lazzaro
et al., 1997). While not itself a risk gene for schizophrenia, it plays
a role in the Wnt signaling pathway (Davidson and Niehrs, 2010),
which has been implicated in the pathogenesis of schizophrenia
[for review, see (Freyberg et al., 2010). GRM6 (metabotropic glu-
tamate receptor 6), though expressed in brain (Allan brain atlas
gene expression), has not been studied for the mental illness yet
and is predominantly associated with visual deficits (O’Connor
et al., 2006). Furthermore, it is a member of the mGlu group
III receptors, of which GRM7 and GRM8 have been implicated
in schizophrenia in Japanese populations, e.g., (Takaki et al.,
2004; Shibata et al., 2009)], and subgroups of the mGlu receptors
are promising therapeutic targets for schizophrenia (Wieronska
and Pilc, 2009). The simultaneous implication of mGlu receptors
and the activations within a network containing the thalamus is
intriguing, given the glutamate receptor alterations in the thala-
mus in schizophrenia (Cronenwett and Csernansky, 2010), but
these results must be considered highly preliminary and we only
see it as an encouraging fact to promote the method.
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Overall, this study is primarily a method study with a prelim-
inary application to GWAS. Based on our results on simulation
and real data application, we believe that the ICA with refer-
ence approach enables a flexible but focused way to identify the
genetic factor of interest. Compared to a full, blind source sep-
aration analysis of all SNP data, it is more robust in terms of
extracting the “right” component. When the ICA with reference
on SNP data is analyzed in conjunction with brain images as an
intermediate phenotype, it provides an effective way to analyze
the relation between genetic factors and brain networks. In this
study, we used markers with certain levels of allelic frequency dif-
ference as a reference; it makes the extracted genetic factor biased
toward patients vs. controls difference and thus inflates the sig-
nificance of the t-test on SZ vs. HC difference, but it does not
affect the association test on brain functional network. In fact,
we have used SNPs in gene DRD2 as a reference and extracted
a genetic factor centered at DRD2 function (results not shown).
Yet, this genetic factor did not relate to any brain function in
our image data collected in the auditory oddball task, which pro-
vides evidence that the association of a specific genetic factor with
brain function is not biased. With such a small sample size, we
are aware that the result on real data is limited by identifica-
tion power. Nevertheless, the simulation and real data application
show consistently the capability of ICA with reference to extract
genetic factors of interest. In conclusion, we propose an approach
that provides a particularly useful way to investigate regions of
brain activity associated with specific genetic variation. It can be
applied to the identification of certain (gene-specific, pathway-
specific, etc.) genetic factors from a large genomic array, and the
study of specific genetic effect on brain function. We also provide
an example of such application that demonstrates the ability to
extract genetic factors, analyze inter-SNP relation, identify asso-
ciated brain network and suggest the genetic (minor allelic) effect
on brain.We hope to see the adoption of ourmethod in the future
GWAS researches.
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